XKRX
071200
Market cap193mUSD
Oct 08, Last price
10,750.00KRW
1D
-5.95%
1Q
21.33%
Jan 2017
56.71%
IPO
104.37%
Name
Infinitt Healthcare Co Ltd
Chart & performance
P/E
5.92
P/S
2.56
EPS
1,817.05
Div yield, %
0.93%
Shrs. gr., 5y
-0.12%
Rev. gr., 5y
6.46%
Revenues
101.57b
+10.38%
Net income
43.92b
+129.50%
CFO
11.99b
+17.33%
Dividend
May 06, 2026100 KRW/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Infinitt Healthcare Co Ltd is a South Korea-based firm specializing in the development of advanced digital healthcare solutions for medical facilities. Their comprehensive product line is structured into clinical, enterprise imaging, and radiology solutions. The clinical offerings encompass specialized systems such as Cardiology PACS, digital pathology platforms, 3D visualization tools, 3D printing services, and radiation oncology information management systems, among others. For radiology departments, their portfolio includes essential technologies like Picture Archiving and Communication Systems (PACS), Radiology Information Systems (RIS), data analytics tools, cloud-based PACS, and teleradiology solutions.
Key people
Chairman of the Board, Co-Chief Executive Officer · since 2013
Co-Chief Executive Officer, Vice President, Director · since 2013
Chang Jin Cha
Managing Director
Du Gyu Ryu
Managing Director
Chang Yong Cho
Internal Auditor · since 2012
Director · since 2011
Director · since 2011
Yin Cheol Ryu
Non-Executive Independent Director · since 2012
Valuation
Title KRW in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||